Suite 101, No.1011 Halei Rd.,
shanghai, 201203
China
Tel: (+86) 21-58558330
Fax: (+86) 21-58558011

operation@hdbiosciences.com

Welcome To HD Biosciences
HD Biosciences Co., Ltd. is a Shanghai based biotech company, specializing in high value drug discovery contract research services. HD Biosciences has developed comprehensive technology platforms and expertise around drug discovery assays/assay development, high throughput drug screening, and hit-to-lead biology, as well as natural product based lead compound discovery.
News & Events
HD Biosciences Announces the Appointment of Senior Vice President of Discovery Biology. Sept. 8, 2008 -- HD Biosciences Inc. (HDB) announces the hiring of Dr. Peiyuan Lin as Senior Vice President of Discovery Biology.
HD Biosciences Announces the Appointment of Head of Business Development and Project Development. Sept. 8, 2008 -- HD Biosciences Inc. (HDB) announces the hiring of Dr. Angela Chen as Head of Business Development and Project Management.
HD Biosciences Announces Completion of Series A Financing. The current round was co-led by Morningside Venture, a private investment group founded by Hong Kong's Chan family, and Lilly Asian Ventures, the Asian venture arm of Eli Lilly & Co. And Pfizer Venture Investments, the venture arm of Pfizer Inc, also participated in this round.
HD Biosciences Announces the Appointment of VP of DMPK and Bioanalytical Services. July 16, 2008 -- HD Biosciences Inc. (HDB) today announces the hiring of Dr. Frances Wang as VP of DMPK and bioanalytical services.
HD Biosciences Announces the Appointment of VP of HTS Screening. July 7, 2008 -- HD Biosciences Inc. (HDB) announces the hiring of Dr. Shaoming Huang as Vice President, High Throughput Screening (HTS).
HD Biosciences, Sundia, and European Company NovaSecta Join CRO Service Alliance for Drug Discovery Solutions.